Found 4 matching trials
First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors
PHASE1The purpose of this study is to determine whether BMS-986218 both by itself...
Location
Local Institution - 0058
Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer
EARLY_PHASE1The purpose of this study is to see whether immunotherapy with BMS-986218 a...
Location
Columbia University Irving Medical Center
A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer
PHASE2The purpose of this study is to assess the safety, efficacy, tolerability, ...
Location
Arizona Oncology - Tucson - Wilmot Road Location
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
PHASE1This phase I/II trial studies the side effects of anti-CTLA4-NF monoclonal ...
Location
M D Anderson Cancer Center